Dupilumab
Last Updated: 11/08/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5584 publications
Contemporary pharmacotherapeutic management of severe pediatric asthma.
Journal: Expert opinion on pharmacotherapy
Published: October 30, 2026
Retronasal olfactory recovery during biologic therapy for chronic rhinosinusitis with nasal polyps: a prospective longitudinal study with parallel orthonasal assessment.
Journal: Rhinology
Published: October 30, 2026
The new revolution in the treatment of chronic urticaria, present and future of an effective and safe approach.
Journal: Italian journal of dermatology and venereology
Published: October 29, 2026
Atopic biologic use and recalled irritable bowel syndrome symptom severity: A hypothesis generating retrospective survey evaluation.
Journal: Allergy and asthma proceedings
Published: October 29, 2026
Associations between use of targeted therapies, hospitalizations, and emergency department visits among patients with atopic dermatitis: A retrospective cohort study.
Journal: Journal of managed care & specialty pharmacy
Published: October 24, 2026
Letter: Increased Rate of Ocular Disease Following Atopic Dermatitis Treatment with Dupilumab: An International Retrospective Study.
Journal: Dermatitis : contact, atopic, occupational, drug
Published: October 23, 2026
Biologics in alopecia areata: promise, paradox, and the precision medicine frontier.
Journal: Expert opinion on biological therapy
Published: October 22, 2026
Therapeutic utility of clinical & laboratory markers in chronic spontaneous urticaria - a narrative review.
Journal: Expert review of clinical pharmacology
Published: October 22, 2026
Real-world evidence on dupilumab dose spacing and tolerability in children with atopic dermatitis.
Journal: European journal of dermatology : EJD
Published: October 22, 2026
Planned Biologic Discontinuation in Severe Asthma: A Systematic Review and Meta-Analysis.
Journal: The Journal of asthma : official journal of the Association for the Care of Asthma
Published: October 20, 2026
Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitis.
Journal: The Journal of dermatological treatment
Published: October 19, 2026
Last Updated: 11/08/2026